A Crossover, Multicentre, Randomised Trial Comparing the Effect on the Control of Blood Glucose Concentration of Insulin Glargine and Insulin Detemir, Combined With Insulin Glulisine, Used as a Bolus, in Type 1 Diabetic Patients.

Trial Profile

A Crossover, Multicentre, Randomised Trial Comparing the Effect on the Control of Blood Glucose Concentration of Insulin Glargine and Insulin Detemir, Combined With Insulin Glulisine, Used as a Bolus, in Type 1 Diabetic Patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 03 Feb 2010

At a glance

  • Drugs Insulin detemir; Insulin glargine; Insulin glulisine
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms VARIABILITE
  • Sponsors Sanofi
  • Most Recent Events

    • 07 Jul 2009 Additional lead trial investigator (Sebille M) identified as reported by ClinicalTrials.gov.
    • 05 Oct 2008 Actual end date Sep 2008 added as reported by CT.gov
    • 05 Oct 2008 number of patients changed from 86 to 88 as reported by CT.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top